This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

IMRIS Receives Innovation In Medical Devices Award By MN Business Magazine

Stocks in this article: IM IMRS

VISIUS iCT is latest leading edge technology for intraoperative imaging solutions

MINNEAPOLIS, Oct. 30, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") announced that the company has received the 2013 Innovation in Medical Devices Award from Minnesota Business Magazine in recognition for significantly improving medical technology with the launch of its VISIUS ® iCT. The awards were announced Oct. 29 during a dinner ceremony at the Hyatt Regency Minneapolis.

"As the global leader in intraoperative image-guided solutions, we anticipate that VISIUS iCT will be an invaluable tool for spine and neurosurgery and trauma, just as our VISIUS iMRI is now for cranial and skull-base neurosurgery," said Jay D. Miller, IMRIS President and CEO. "IMRIS is delighted for this recognition after recently joining the Twin Cities business community which is at the heart of world-class medical device innovation." IMRIS relocated its operations to Minnetonka from Winnipeg in early 2013.

VISIUS iCT, the newest IMRIS product approved by the U.S. Food and Drug Administration in July, improves spinal and orthopaedic surgery by bringing state-of-the-art computed tomography (CT) imaging to the patient during procedures by mounting the scanner on ceiling rails that transport the scanner to the patient. Surgical precision and patient outcomes are improved when the surgeon has access to this high-quality imaging during the procedure. Other types of intraoperative X-ray based imaging on the market occupy valuable OR floor space and do not match the image resolution and applications available with VISIUS iCT.

Developed for the neurosurgery and spine surgery markets, VISIUS iCT also features advanced software applications that maximize image quality while minimizing radiation exposure in real time and industry leading post-processing software to enhance surgical diagnosis and intervention.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs